The abstract reports on the clinical outcome for patients having undergone a two-stage treatment with a combination of Episurf Medical's personalised knee implant Episealer®, and knee osteotomy, for treatment of chondral and osteochondral defects in the knee, at Maria-Josef-Hospital, Greven, Germany.

"We appreciate the continued interested in the clinical outcome for patients treated with our Episealer® Knee implants. This specific study is highly interesting as it is the first study with follow-up of patients who have undergone a combination of joint preserving treatment alternatives, potentially allowing treatment of more severe defects than each of the interventions alone could have treated", says Pål Ryfors, CEO Episurf Medical.